ABSTRACT
RESUMEN: La enfermedad periodontal se clasifica en dos grandes grupos principales: gingivitis y periodontitis, desencadenadas por una alteración de la microbiota oral, que causa un aumento de microorganismos patógenos con respecto a los beneficiosos. Estos, en interacción con el hospedero y con los factores de riesgo del paciente, definirán una presentación clínica específica. Una de las estrategias que se propone como alternativa frente al uso de antibióticos y como coadyuvante del raspado y alisado radicular (RAR) para tratar las periodontitis, es la administración de probióticos. Los probióticos son denominados como microorganismos vivos que al ser administrados en cantidades adecuadas son capaces de ejercer una acción benéfica sobre la salud del hospedador. Por tanto, el objetivo de este trabajo fue describir el beneficio de los probióticos en la prevención y tratamiento de las principales enfermedades periodontales. Para ello, se realizó una búsqueda desde Enero del 2010 a Mayo del 2020 en Pubmed, Web of Science, SciELO, Science Direct y el Portal Timbó. Obteniéndose como resultado que los probióticos son capaces de reducir los parámetros clínicos y microbiológicos de dichas enfermedades y que pueden ser un valioso complemento en su prevención y tratamiento.
ABSTRACT: Periodontal disease is classified into two main groups: gingivitis and periodontitis, triggered by an alteration of the oral microbiota, which causes an increase in pathogenic microorganisms with respect to the beneficial ones. In interaction with the host and with the risk factors of the patient. They will define a specific clinical presentation. One of the strategies proposed as an alternative to the use of antibiotics and as an adjunct to scraping and root planning (RAR) to treat periodontitis, is the administration of probiotics. Probiotics are living microorganisms that, when administered in adequate amounts, are capable of exerting a beneficial action on the health of the host. Therefore, the objective of this work was to describe the benefit of probiotics in the prevention and treatment of the main periodontal diseases. For this, a search was carried out between 2010 and 2020 in PubMed, Web of Science, SciELO, Science Direct and the Timbó Portal. The results obtained showed that probiotics are capable of reducing the clinical and microbiological parameters of these diseases and that they can be a valuable complement in their prevention and treatment.
Subject(s)
Humans , Periodontal Diseases , Periodontitis , Probiotics , GingivitisABSTRACT
BACKGROUND: Odontogenic keratocyst (OKC) is a development cyst, of odontogenic origin, that differs from other entities by its infiltrating and aggressive biological behavior. Among conservative treatments for large lesions, surgical decompression stands out, with a variable recurrence rate. Aim: To evaluate the histological effects of decompression treatment on OKC, including cell proliferation and apoptosis of epithelial cyst. MATERIAL AND METHODS: 21 OKC cases were included. Samples were taken before and after surgical decompression for histological evaluation and immunohistochemical staining of Ki-67, MCM4/7, Bax and Bcl2. Data were analyzed and compared using Student's t and Wilcoxon tests for related samples, and p values <0,05 were considered statistically significant. RESULTS: After decompression treatment an increase in inflammation of the cystic wall (p=0,029), loss of parakeratinization of the epithelium (p=0,007) and absence of palisade cell distribution in the basal layer were observed (p=0,002). There were no statistically significant changes in the expression of Ki-67 (p=0,323), MCM4/7 (p=0,079), Bax (p=0,392) or Bcl-2 when compared before and after decompression. CONCLUSIONS: Surgical decompression generates histological structural changes in OKC both in the epithelium and connective wall, however, these findings do not seem to alter induction of the cell cycle or epithelial apoptosis. Key words:Odontogenic keratocyst, MCM, Bax, Bcl2, Ki-67, apoptosis, decompression.
